AstraZeneca initiates first-in-human study of AZD-4041 in healthy volunteers Oct. 15, 2019 No Comments
Humanetics' development of radioprotectant BIO-301 supported by DoD cooperative research agreement Oct. 2, 2019 No Comments
Emergent BioSolutions, Indivior win NIH grants to study drugs for opioid use disorder Sep. 30, 2019 No Comments
Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction Sep. 18, 2019 No Comments
Preclinical characterization of novel mGlu2 receptor PAMs for the treatment of substance abuse Sep. 10, 2019 No Comments
Discovery of a selective OX1 receptor antagonist for substance abuse and dependency Sep. 5, 2019 No Comments